These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 25479564)
1. Adenovirus 36 attenuates weight loss from exercise but improves glycemic control by increasing mitochondrial activity in the liver. Na HN; Hong YM; Ye MB; Park S; Kim IB; Nam JH PLoS One; 2014; 9(12):e114534. PubMed ID: 25479564 [TBL] [Abstract][Full Text] [Related]
2. Template to improve glycemic control without reducing adiposity or dietary fat. Krishnapuram R; Dhurandhar EJ; Dubuisson O; Kirk-Ballard H; Bajpeyi S; Butte N; Sothern MS; Larsen-Meyer E; Chalew S; Bennett B; Gupta AK; Greenway FL; Johnson W; Brashear M; Reinhart G; Rankinen T; Bouchard C; Cefalu WT; Ye J; Javier R; Zuberi A; Dhurandhar NV Am J Physiol Endocrinol Metab; 2011 May; 300(5):E779-89. PubMed ID: 21266671 [TBL] [Abstract][Full Text] [Related]
4. Adenovirus 36 as an obesity agent maintains the obesity state by increasing MCP-1 and inducing inflammation. Na HN; Nam JH J Infect Dis; 2012 Mar; 205(6):914-22. PubMed ID: 22275403 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of adipose tissue macrophages and macrophage-derived insulin-like growth factor-1 in virus-induced obesity. Park S; Park HL; Lee SY; Nam JH Int J Obes (Lond); 2016 Mar; 40(3):460-70. PubMed ID: 26395748 [TBL] [Abstract][Full Text] [Related]
6. Human adenovirus Ad36 and its E4orf1 gene enhance cellular glucose uptake even in the presence of inflammatory cytokines. Na HN; Dubuisson O; Hegde V; Nam JH; Dhurandhar NV Biochimie; 2016 May; 124():3-10. PubMed ID: 25450249 [TBL] [Abstract][Full Text] [Related]
7. Long-term changes in adiposity and glycemic control are associated with past adenovirus infection. Lin WY; Dubuisson O; Rubicz R; Liu N; Allison DB; Curran JE; Comuzzie AG; Blangero J; Leach CT; Göring H; Dhurandhar NV Diabetes Care; 2013 Mar; 36(3):701-7. PubMed ID: 23160725 [TBL] [Abstract][Full Text] [Related]
8. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. Trovato GM; Martines GF; Trovato FM; Pirri C; Pace P; Garozzo A; Castro A; Catalano D Dig Dis Sci; 2012 Feb; 57(2):535-44. PubMed ID: 21953137 [TBL] [Abstract][Full Text] [Related]
9. Human obesity relationship with Ad36 adenovirus and insulin resistance. Trovato GM; Castro A; Tonzuso A; Garozzo A; Martines GF; Pirri C; Trovato F; Catalano D Int J Obes (Lond); 2009 Dec; 33(12):1402-9. PubMed ID: 19786969 [TBL] [Abstract][Full Text] [Related]
10. Adenovirus 36 improves glycemic control and markers of Alzheimer's disease pathogenesis. Hegde V; Vijayan M; Kumar S; Akheruzzaman M; Sawant N; Dhurandhar NV; Reddy PH Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165531. PubMed ID: 31398466 [TBL] [Abstract][Full Text] [Related]
11. Proof-of-concept for a virus-induced obesity vaccine; vaccination against the obesity agent adenovirus 36. Na HN; Nam JH Int J Obes (Lond); 2014 Nov; 38(11):1470-4. PubMed ID: 24614097 [TBL] [Abstract][Full Text] [Related]
12. Role of adenoviruses in obesity. Voss JD; Atkinson RL; Dhurandhar NV Rev Med Virol; 2015 Nov; 25(6):379-87. PubMed ID: 26352001 [TBL] [Abstract][Full Text] [Related]
13. Obesity-independent association of human adenovirus Ad37 seropositivity with nonalcoholic fatty liver disease. Trovato GM; Martines GF; Pirri C; Trovato FM; Castro A; Garozzo A; Catalano D J Clin Gastroenterol; 2012 Jul; 46(6):e46-54. PubMed ID: 22476041 [TBL] [Abstract][Full Text] [Related]
14. Association of adenovirus 36 infection with adiposity and inflammatory-related markers in children. Berger PK; Pollock NK; Laing EM; Warden SJ; Hill Gallant KM; Hausman DB; Tripp RA; McCabe LD; McCabe GP; Weaver CM; Peacock M; Lewis RD J Clin Endocrinol Metab; 2014 Sep; 99(9):3240-6. PubMed ID: 24926952 [TBL] [Abstract][Full Text] [Related]
15. Tracking Study About Adenovirus 36 Infection: Increase of Adiposity. Park S; Kim J; Shin HJ; Hong YM; Sheen YH; Park HL; Jeon HJ; Ahn SY; Nam JH J Microbiol Biotechnol; 2015 Dec; 25(12):2169-72. PubMed ID: 26428735 [TBL] [Abstract][Full Text] [Related]
16. Accurate identification of neutralizing antibodies to adenovirus Ad36, -a putative contributor of obesity in humans. Dubuisson O; Day RS; Dhurandhar NV J Diabetes Complications; 2015; 29(1):83-7. PubMed ID: 25312598 [TBL] [Abstract][Full Text] [Related]
17. Improvement in Glycemic Control in Mice of Different Age Groups. Gamage S; Peddibhotla S; Reddy PH; Dhurandhar NV; Hegde V Exp Clin Endocrinol Diabetes; 2021 Jul; 129(7):519-527. PubMed ID: 31340394 [TBL] [Abstract][Full Text] [Related]
18. Twenty-five years of research about adipogenic adenoviruses: A systematic review. Akheruzzaman M; Hegde V; Dhurandhar NV Obes Rev; 2019 Apr; 20(4):499-509. PubMed ID: 30562840 [TBL] [Abstract][Full Text] [Related]
19. Association of adenovirus 36 infection with obesity and metabolic markers in humans: a meta-analysis of observational studies. Yamada T; Hara K; Kadowaki T PLoS One; 2012; 7(7):e42031. PubMed ID: 22848697 [TBL] [Abstract][Full Text] [Related]
20. Acute effect of infection by adipogenic human adenovirus Ad36. Pasarica M; Loiler S; Dhurandhar NV Arch Virol; 2008; 153(11):2097-102. PubMed ID: 18830560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]